Search research articles
Contact Us
Filters
Showing results (111-120 of 200) with videos related to
Page
of 20
Sort By:
Blood Advances
|
January 19, 2018
Prognostic significance of cytogenetic heterogeneity in patients with newly diagnosed multiple myeloma
Maximilian Merz, Anna Jauch, Thomas Hielscher, et al.
Blood
|
July 3, 2010
Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trial
Peter Dreger, Hartmut Döhner, Matthias Ritgen, et al.
Blood
|
December 18, 2010
Testing G-CSF responsiveness predicts the individual susceptibility to infection and consecutive treatment in recipients of high-dose chemotherapy
Christian Straka, Michael Sandherr, Hans Salwender, et al.
European Journal of Haematology
|
November 11, 2025
Prognostic Impact of the Hevylite Assay in Patients With IgG or IgA Multiple Myeloma Treated Within the GMMG-MM5 Trial
Tim Richardson, Elias Mai, Ekaterina Menis, et al.
Bone Marrow Transplantation
|
November 19, 2022
Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome unclassifiable - a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
Joanna Drozd-Sokolowska, Luuk Gras, Nienke Zinger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 29, 2017
Post-Transplantation Cyclophosphamide-Based Haploidentical Transplantation as Alternative to Matched Sibling or Unrelated Donor Transplantation for Hodgkin Lymphoma: A Registry Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation
Carmen Martínez, Jorge Gayoso, Carmen Canals, et al.
Blood Cancer Journal
|
August 29, 2019
Cystic transformation of focal lesions after therapy is associated with remission but adverse outcome in myeloma
Maximilian Merz, Thomas Hielscher, Elias Karl Mai, et al.
Haematologica
|
March 5, 2026
Impact of FMS-like tyrosine kinase 3 inhibitor maintenance on post-transplant outcomes in acute myeloid leukemia with FMS-like tyrosine kinase 3 mutations: a real-world German registry analysis highlighting sorafenib
Radwan Massoud, Sarah Flossdorf, Franziska Hanke, et al.
Leukemia
|
December 22, 2022
Retrospective analysis of hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: conditioning intensity matters
Peter-Martin Bruch, Sascha Dietrich, Herve Finel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 7, 2013
Second allograft for hematologic relapse of acute leukemia after first allogeneic stem-cell transplantation from related and unrelated donors: the role of donor change
Maximilian Christopeit, Oliver Kuss, Jürgen Finke, et al.
Page
of 20
Search research articles
Search
Showing results (111-120 of 200) with videos related to
Sort By:
Page
of 20
Blood Advances
|
January 19, 2018
Prognostic significance of cytogenetic heterogeneity in patients with newly diagnosed multiple myeloma
Maximilian Merz, Anna Jauch, Thomas Hielscher, et al.
Blood
|
July 3, 2010
Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trial
Peter Dreger, Hartmut Döhner, Matthias Ritgen, et al.
Blood
|
December 18, 2010
Testing G-CSF responsiveness predicts the individual susceptibility to infection and consecutive treatment in recipients of high-dose chemotherapy
Christian Straka, Michael Sandherr, Hans Salwender, et al.
European Journal of Haematology
|
November 11, 2025
Prognostic Impact of the Hevylite Assay in Patients With IgG or IgA Multiple Myeloma Treated Within the GMMG-MM5 Trial
Tim Richardson, Elias Mai, Ekaterina Menis, et al.
Bone Marrow Transplantation
|
November 19, 2022
Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome unclassifiable - a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
Joanna Drozd-Sokolowska, Luuk Gras, Nienke Zinger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 29, 2017
Post-Transplantation Cyclophosphamide-Based Haploidentical Transplantation as Alternative to Matched Sibling or Unrelated Donor Transplantation for Hodgkin Lymphoma: A Registry Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation
Carmen Martínez, Jorge Gayoso, Carmen Canals, et al.
Blood Cancer Journal
|
August 29, 2019
Cystic transformation of focal lesions after therapy is associated with remission but adverse outcome in myeloma
Maximilian Merz, Thomas Hielscher, Elias Karl Mai, et al.
Haematologica
|
March 5, 2026
Impact of FMS-like tyrosine kinase 3 inhibitor maintenance on post-transplant outcomes in acute myeloid leukemia with FMS-like tyrosine kinase 3 mutations: a real-world German registry analysis highlighting sorafenib
Radwan Massoud, Sarah Flossdorf, Franziska Hanke, et al.
Leukemia
|
December 22, 2022
Retrospective analysis of hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: conditioning intensity matters
Peter-Martin Bruch, Sascha Dietrich, Herve Finel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 7, 2013
Second allograft for hematologic relapse of acute leukemia after first allogeneic stem-cell transplantation from related and unrelated donors: the role of donor change
Maximilian Christopeit, Oliver Kuss, Jürgen Finke, et al.
Page
of 20